1998
DOI: 10.1002/pro.5560070610
|View full text |Cite
|
Sign up to set email alerts
|

Comparative analysis of the noncollagenous NC1 domain of type IV collagen: Identification of structural features important for assembly, function, and pathogenesis

Abstract: Type IV collagen al-a6 chains have important roles in the assembly of basement membranes and are implicated in the pathogenesis of Goodpasture syndrome, an autoimmune disorder, and Alport syndrome, a hereditary renal disease. We report comparative sequence analyses and structural predictions of the noncollagenous C-terminal globular NCl domain (28 sequences). The inferred tree verified that type IV collagen sequences fall into two groups, a1-like and a2-like, and suggested that vertebrate a3/a4 sequences evolv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
31
0
5

Year Published

2001
2001
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 54 publications
(38 citation statements)
references
References 59 publications
2
31
0
5
Order By: Relevance
“…Since a quantitative data analysis was not reported in that study, it is difficult to directly compare their findings with ours. A very recent paper from the same group (24) quantitatively analyzed the role of four ␣3 residues in the E A region and found Val 27 to be critical for GP antibody binding (similar to our findings), whereas Thr 17 , Ala 18 , and Glu 24 had a moderate effect. Some of the discrepancies may be explained by the different ␣1/␣3 chimeras used as template for the homolog-scanning mutagenesis.…”
Section: Discussionsupporting
confidence: 89%
See 2 more Smart Citations
“…Since a quantitative data analysis was not reported in that study, it is difficult to directly compare their findings with ours. A very recent paper from the same group (24) quantitatively analyzed the role of four ␣3 residues in the E A region and found Val 27 to be critical for GP antibody binding (similar to our findings), whereas Thr 17 , Ala 18 , and Glu 24 had a moderate effect. Some of the discrepancies may be explained by the different ␣1/␣3 chimeras used as template for the homolog-scanning mutagenesis.…”
Section: Discussionsupporting
confidence: 89%
“…The ␣3(IV) NC1 sequence was analyzed with the program Epiplot, which calculates and plots flexibility, hydrophilicity, and antigenicity profiles using 13 different scales, chosen as those yielding the best predictions on proteins whose antigenic structures are known (20). None of 27 , and Pro 28 are critical for the GP A epitope (diagonal lines). One or more of these GP A residues are buried within the NC1 hexamer by hydrophobic interactions with residues of other NC1 domains, rendering the epitope cryptic and inaccessible for antibody binding (left).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The presence of both reducible and nonreducible NC1 dimers have been repeatedly reported in different tissues such as kidney, placenta, aorta, and mouse Engelbreth-Holm-Swarm tumor Langeveld et al, 1988;Siebold et al, 1988;Weber et al, 1984). Such dimers have long been assumed to be disulfide crosslinked monomers formed through a reshuffling mechanism of disulfide bonds during network formation (Netzer et al, 1998b;Siebold et al, 1988). However, the relative amount of nonreducible dimers isolated from different tissues varies significantly, for example 70% in BM of placenta but only 30% in BM of lens capsule Vanacore et al, 2004).…”
Section: Biosynthesis and Modificationsmentioning
confidence: 96%
“…The C-terminal fragment of the progollagen C-terminal proteinase enhancer protein was purified from human brain tumor cells due to its MMP-inhibitory activity, but it is a less potent inhibitor than the TIMPs (Mott et al, 2000). The noncollagenous NC1 domains of collagen type IV are another protein domains with structural similarities to TIMPs (Netzer et al, 1998). Among the NC1 domains of collagen type IV, the α3 chain NC1 domain is the most potent inhibitor of angiogenesis and tumor growth (Petitclerc et al, 2000).…”
Section: Gelatinase Inhibitors Naturally Occuring Gelatinase Inhibitorsmentioning
confidence: 99%